Current Report Filing

The Oncology Institute, Inc. filed a Current Report on Form 8-K dated March 13, 2026. The report includes an investor presentation, furnished as Exhibit 99.1, which the Company will use in investor meetings. The presentation details are not deemed "filed" under Section 18 of the Exchange Act and do not be incorporated by reference into other filings. The filing also lists the company's common stock (TOI) and redeemable warrants (TOIIW) traded on The Nasdaq Stock Market LLC. Robert Carter, Chief Financial Officer, signed the report on behalf of the company.